These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 17348989

  • 1. Dutasteride improves male pattern hair loss in a randomized study in identical twins.
    Stough D.
    J Cosmet Dermatol; 2007 Mar; 6(1):9-13. PubMed ID: 17348989
    [Abstract] [Full Text] [Related]

  • 2. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
    Gubelin Harcha W, Barboza Martínez J, Tsai TF, Katsuoka K, Kawashima M, Tsuboi R, Barnes A, Ferron-Brady G, Chetty D.
    J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
    [Abstract] [Full Text] [Related]

  • 3. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study.
    Eun HC, Kwon OS, Yeon JH, Shin HS, Kim BY, Ro BI, Cho HK, Sim WY, Lew BL, Lee WS, Park HY, Hong SP, Ji JH.
    J Am Acad Dermatol; 2010 Aug; 63(2):252-8. PubMed ID: 20605255
    [Abstract] [Full Text] [Related]

  • 4. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.
    Olsen EA, Hordinsky M, Whiting D, Stough D, Hobbs S, Ellis ML, Wilson T, Rittmaster RS, Dutasteride Alopecia Research Team.
    J Am Acad Dermatol; 2006 Dec; 55(6):1014-23. PubMed ID: 17110217
    [Abstract] [Full Text] [Related]

  • 5. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
    Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AG, Savin RC, Tharp MD.
    J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
    [Abstract] [Full Text] [Related]

  • 6. Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients.
    Kaufman KD, Girman CJ, Round EM, Johnson-Levonas AO, Shah AK, Rotonda J.
    Eur J Dermatol; 2008 Apr; 18(4):407-11. PubMed ID: 18573713
    [Abstract] [Full Text] [Related]

  • 7. Finasteride in the treatment of Japanese men with male pattern hair loss.
    Kawashima M, Hayashi N, Igarashi A, Kitahara H, Maeguchi M, Mizuno A, Murata Y, Nogita T, Toda K, Tsuboi R, Ueki R, Yamada M, Yamazaki M, Matsuda T, Natsumeda Y, Takahashi K, Harada S.
    Eur J Dermatol; 2004 Apr; 14(4):247-54. PubMed ID: 15319158
    [Abstract] [Full Text] [Related]

  • 8. Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss.
    Roberts JL, Fiedler V, Imperato-McGinley J, Whiting D, Olsen E, Shupack J, Stough D, DeVillez R, Rietschel R, Savin R, Bergfeld W, Swinehart J, Funicella T, Hordinsky M, Lowe N, Katz I, Lucky A, Drake L, Price VH, Weiss D, Whitmore E, Millikan L, Muller S, Gencheff C.
    J Am Acad Dermatol; 1999 Oct; 41(4):555-63. PubMed ID: 10495375
    [Abstract] [Full Text] [Related]

  • 9. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.
    Finasteride Male Pattern Hair Loss Study Group.
    Eur J Dermatol; 2002 Oct; 12(1):38-49. PubMed ID: 11809594
    [Abstract] [Full Text] [Related]

  • 10. Adenosine increases anagen hair growth and thick hairs in Japanese women with female pattern hair loss: a pilot, double-blind, randomized, placebo-controlled trial.
    Oura H, Iino M, Nakazawa Y, Tajima M, Ideta R, Nakaya Y, Arase S, Kishimoto J.
    J Dermatol; 2008 Dec; 35(12):763-7. PubMed ID: 19239555
    [Abstract] [Full Text] [Related]

  • 11. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.
    Blume-Peytavi U, Lönnfors S, Hillmann K, Garcia Bartels N.
    J Am Acad Dermatol; 2012 May; 66(5):794-800. PubMed ID: 21875758
    [Abstract] [Full Text] [Related]

  • 12. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
    Price VH, Roberts JL, Hordinsky M, Olsen EA, Savin R, Bergfeld W, Fiedler V, Lucky A, Whiting DA, Pappas F, Culbertson J, Kotey P, Meehan A, Waldstreicher J.
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
    [Abstract] [Full Text] [Related]

  • 13. Pilot study of a novel treatment for androgenetic alopecia using enriched cell culture medium: clinical trials.
    Lindenbaum ES, Feitelberg AL, Tendler M, Beach D, Gamliel-Lazarovich A, Har-Shai Y, Hirshowitz B.
    Dermatol Online J; 2003 Feb; 9(1):4. PubMed ID: 12639462
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss.
    Whiting DA, Olsen EA, Savin R, Halper L, Rodgers A, Wang L, Hustad C, Palmisano J, Male Pattern Hair Loss Study Group.
    Eur J Dermatol; 2003 Feb; 13(2):150-60. PubMed ID: 12695131
    [Abstract] [Full Text] [Related]

  • 15. Effective treatment of female androgenic alopecia with dutasteride.
    Olszewska M, Rudnicka L.
    J Drugs Dermatol; 2005 Feb; 4(5):637-40. PubMed ID: 16167423
    [Abstract] [Full Text] [Related]

  • 16. The effect of dutasteride on the efficacy of photoselective vaporization of the prostate: results of a randomized, placebo-controlled, double-blind study (DOP trial).
    Bepple JL, Barone BB, Eure G.
    Urology; 2009 Nov; 74(5):1101-4. PubMed ID: 19800668
    [Abstract] [Full Text] [Related]

  • 17. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.
    Shanshanwal SJ, Dhurat RS.
    Indian J Dermatol Venereol Leprol; 2017 Nov; 83(1):47-54. PubMed ID: 27549867
    [Abstract] [Full Text] [Related]

  • 18. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
    Arca E, Açikgöz G, Taştan HB, Köse O, Kurumlu Z.
    Dermatology; 2004 Nov; 209(2):117-25. PubMed ID: 15316165
    [Abstract] [Full Text] [Related]

  • 19. Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.
    Price VH, Menefee E, Sanchez M, Kaufman KD.
    J Am Acad Dermatol; 2006 Jul; 55(1):71-4. PubMed ID: 16781295
    [Abstract] [Full Text] [Related]

  • 20. Long-term sustained improvement in symptoms of benign prostatic hyperplasia with the dual 5alpha-reductase inhibitor dutasteride: results of 4-year studies.
    Roehrborn CG, Lukkarinen O, Mark S, Siami P, Ramsdell J, Zinner N.
    BJU Int; 2005 Sep; 96(4):572-7. PubMed ID: 16104912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.